Acalabrutinib
Zanubrutinib
Update Venetoclax in CLL
Obinutuzumab
UpToDate
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
Cancer.gov
ASCO: COVID-19 Medical Resources